Clinical trials for multiple myeloma

brought to you by Smart Patients

Trials for:

Enter a 5 digit zipcode to filter trials by distance.

multiple myeloma
treatments
6
phase 1
9
phase 2
6
phase 3
1
other*
targeted therapy
carfilzomib (Kyprolis)
3 3 1 0
ixazomib (Ninlaro)
0 1 1 0
ONC201
1 0 0 0
bortezomib (Velcade)
2 2 3 0
immunotherapy
daratumumab (Darzalex)
1 0 2 0
durvalumab (MEDI4736)
1 0 0 0
elotuzumab (Empliciti)
1 2 0 0
pembrolizumab (Keytruda)
0 1 1 0
marrow infiltrating lymphocytes (MILs)
0 1 0 0
MEDI-551
0 0 0 1
pomalidomide (Pomalyst)
1 0 0 0
lenalidomide (Revlimid)
4 7 3 1
transplant
stem cell transplant
0 1 0 0
chemotherapy
bendamustine (Treanda)
1 1 0 0
cisplatin (Platinol)
0 1 1 0
cyclophosphamide (Cytoxan, Endoxan)
0 2 1 0
doxorubicin (Doxil, Adriamycin)
0 1 1 0
etoposide (Lastet, Vepesid)
0 1 1 0
melphalan flufenamide (Melflufen)
1 1 2 0
thalidomide (Synovir, Thalomid)
1 1 1 0

* Phase 4, completed, or compassionate care study

Note that the table does not include trials for MGUS because there are currently no interventional trials for MGUS recruiting in the United States.

The table shows only open trials (recruiting, not yet recruiting, or expanded access) in the United States. For more options, use the search box below.

search for clinical trials